Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group.

Source:http://linkedlifedata.com/resource/pubmed/id/10025887

Download in:

View as

General Info

PMID
10025887